H&F Corporate Investors X, Ltd.
CIK 1901930 · View on SEC EDGAR ↗
- Portfolio value
- $2.8B
- Positions
- 1
- As of
- June 30, 2026
#1,228 of 9,443 by 13F value · top 13.0%
Portfolio value QoQ: -27.4% 13F does not disclose cash
- Top 10 holdings weight
- 100.00%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 1
- Effective number of positions
- 1.0
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 0.0% Est. buys $0 · sells $615,231,304
- New positions
- 0
- Increased
- 0
- Decreased
- 1
- Closed
- 0
On this page
Performance vs S&P 500
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Priceable coverage: 100.0% · Options excluded: 0.0%
Sector breakdown
Other/Unmapped
100.0%
Full portfolio 1 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| MDLN Medline Inc. - Class A common stock | $2,795,283,417 | 100.00% | 70,874,326 | $-1,052,787,200 | Down ×2 | ||
| No matches | |||||||
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| MDLN | Trimmed | -15.6M | -$1.1B |